Virtual ISPOR Europe 2020

Virtual ISPOR Europe 2020

Virtual ISPOR Europe 2020

We will be virtually present at the #ISPOR Europe 2020 congress Join us from November 16 to 19 for the presentation of the following posters:

  • Why Early Access Price Should be Analyzed with Caution?
  • Collecting early Access Real World Evidence DATA for a successful reimbursement appraisal
  • Reference values: country-specific estimates of value of statistical QALY (VSQ)
  • Cost-effectiveness analysis of etonogestrel contraceptive implant compared to six other contraceptive methods based on real life data in France
  • Cost of cardiovascular disease in type2 diabetes in France, a nationwide claims data analysis
  • Health care management of hemophilia A in France: the HEMRAUDE study
  • Economic burden of hemophilia A in france: the HEMRAUDE study
  • Quality of life study in SSc-ILD patients: better understanding the impact of the ILD and the needs of the SSc-ILD patients and their caregivers in France
  • The economic burden of invasive meningococcal disease in France: a case-control retrospective database analysis.
  • Impact of Invasive Meningococcal Disease on Life Expectancy and Socioeconomic Burden in France: A Real World SNIIRAM Database Analysis
  • Health-related quality of life: 4 methodological keys for the French health technology assessment
  • The identification of the pertinent comparators for health technology assessment in France: what are the criteria of the medical and medico-economic assessments?
  • Burden of non-tuberculous mycobacterial lung disease (NTMLD) in France: a claim database analysis